Serotonin and Parkinson's disease.
Hesselink
J M
JM
D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D003866:Depressive Disorder / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D004298:Dopamine / Q000502:physiology; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D012701:Serotonin / Q000502:physiology*; D014364:Tryptophan / Q000627:therapeutic use
D005473:Fluoxetine; D012701:Serotonin; D007980:Levodopa; D014364:Tryptophan; D004298:Dopamine